QIAGEN reports preliminary Q3 2026 results
Business Wire•21/10/2026•17:44 ET
0
Key Highlights
- ➤Q3 net sales $548 million at reported and constant exchange rates
- ➤Adjusted diluted EPS $0.65 at reported and constant exchange rates
- ➤QIAGEN suspends full-year 2026 outlook pending EQT Private Equity transaction
- ➤Full Q3 results scheduled for November 4, 2026
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted earnings per share (EPS) were $0.65, also $0.65 CER.
QIAGEN plans to report full Q3 2026 results on Wednesday, November 4, 2026, at approximately 22:05 Frankfurt time / 16:05 New York time.
Get started
Create a free account to read the full story.